Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival

作者: Azad Kumar , Shruti Purohit , Nilesh Kumar Sharma

DOI: 10.15430/JCP.2016.21.4.227

关键词:

摘要: Breast carcinoma is a heterogeneous disease that has exhibited rapid resistance to treatment in the last decade. Depending genotype and phenotype of breast cancer, there are discernible differences DNA repair protein responses including double strand break repair. It fact different molecular sub-types activate these dedicated pathways distinct manner. The double-strand damage machinery manipulated by selectively or insults inflicted genotoxic effects chemotherapy radiation therapy. two employed homologous recombination non-homologous end joining. In recent decades, therapeutic interventions targeting one more factors involved repairing breaks chemo/radiation therapy have been widely studied. Herein, this review paper summarizes evidence ongoing clinical trials citing potential combinatorial carcinoma.

参考文章(72)
Kathryn J. Chavez, Sireesha V. Garimella, Stanley Lipkowitz, Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer Breast Disease. ,vol. 32, pp. 35- 48 ,(2011) , 10.3233/BD-2010-0307
Omer Dizdar, Cagatay Arslan, Kadri Altundag, Advances in PARP inhibitors for the treatment of breast cancer Expert Opinion on Pharmacotherapy. ,vol. 16, pp. 2751- 2758 ,(2015) , 10.1517/14656566.2015.1100168
Rosa Pennisi, Paolo Ascenzi, Alessandra di Masi, Hsp90: A New Player in DNA Repair? Biomolecules. ,vol. 5, pp. 2589- 2618 ,(2015) , 10.3390/BIOM5042589
Raphael Ceccaldi, Beatrice Rondinelli, Alan D. D’Andrea, Repair Pathway Choices and Consequences at the Double-Strand Break Trends in Cell Biology. ,vol. 26, pp. 52- 64 ,(2016) , 10.1016/J.TCB.2015.07.009
Siker Kimbung, Niklas Loman, Ingrid Hedenfalk, Clinical and molecular complexity of breast cancer metastases. Seminars in Cancer Biology. ,vol. 35, pp. 85- 95 ,(2015) , 10.1016/J.SEMCANCER.2015.08.009
Takayo Fukuda, Wenwen Wu, Maiko Okada, Ichiro Maeda, Yasuyuki Kojima, Ryosuke Hayami, Yasuo Miyoshi, Ko‐ichiro Tsugawa, Tomohiko Ohta, Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage. Cancer Science. ,vol. 106, pp. 1050- 1056 ,(2015) , 10.1111/CAS.12717
Luca Livraghi, Judy E. Garber, PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Medicine. ,vol. 13, pp. 188- 188 ,(2015) , 10.1186/S12916-015-0425-1
Erhong Meng, Ann Hanna, Rajeev Samant, Lalita Shevde, The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer Cancers. ,vol. 7, pp. 1333- 1348 ,(2015) , 10.3390/CANCERS7030839
Brendan D. Price, Alan D. D’Andrea, Chromatin Remodeling at DNA Double-Strand Breaks Cell. ,vol. 152, pp. 1344- 1354 ,(2013) , 10.1016/J.CELL.2013.02.011